MP-SAT作为支原体肺炎患儿疗效监测指标的可行性分析

来源期刊：广州医药 | 87-91 发布时间：2021-11-22 收稿时间：2025/11/13 18:13:36 阅读量：21

作者：: 司徒宝珠,

关键词：: MP-SAT 肺炎支原体肺炎疗效监测可行性; MP-SAT MPP Therapeutic effect Feasibility

DOI：: 10.3969/j.issn.1000-8535.2021.01.017

收稿时间：: 2020-06-08
修订日期：
接收日期：
引用总数：: 0

目的分析肺炎支原体RNA实时荧光恒温扩增技术(MP-SAT)作为肺炎支原体肺炎(MPP)患儿疗效监测指标的可行性。方法选择2017年10月—2018年10月我院儿科收治的因CAP住院的患儿178例为研究对象,其中MPP组80例,非MPP组98例,分别检测血清MP抗体(MP-Ab)和咽拭子MP-RNA,对两种方法检测结果进行统计学分析,以MP-Ab检测为诊断MPP的参照试验,分析MP-SAT诊断MPP的准确性,对MP-SAT和MP-Ab均阳性的MPP病例行动态观察,比较MP-SAT和MP-Ab在患儿不同治疗时间点的检出率,分析MP-SAT转阴时间与临床痊愈时间的相关性,分析MP-SAT转阴时间与MPP患儿临床症状、实验室指标及X线胸片的相关性。结果 MP-SAT和MP-Ab结果不一致的比例在MPP组和非MPP组分别为60.00% (48/80)和19.39%(19/98);MP-SAT、MP-Ab在特异性和阳性预测值方面,差异有统计学意义(P＜0.05);MP-SAT、MP-Ab在敏感度和阴性预测值方面,差异无统计学意义(P＞0.05);MP-SAT、MP-Ab均为阳性28例(35.00%),MP-SAT阳性检出率随治疗时间的延长降低(P＜0.05),MP-Ab阳性检出率随治疗时间的延长升高(P＜0.05);28例临床痊愈时间为(3.11±0.88)周,MP-SAT转阴时间为(3.25±0.74)周,差异无统计学意义(P＞0.05);MP-SAT转阴时间越长的病例表现为发热持续时间越长,X线胸片肺大片实变比例越高,CRP水平越高,LDH水平越高,中性粒细胞百分比越高,淋巴细胞百分比越低(P＜0.05)。结论 MP-SAT作为新一代RNA活菌检测技术在支原体肺炎患儿疗效监测中有较高的价值,值得推广。

Objective To investigate the feasibility of Mycoplasma pneumoniae-simultaneous amplification and testing (MP-SAT)as a monitoring index for children with Mycoplasma pneumoniae pneumonia (MPP). Methods 178 hospitalized children with community-acquired pneumonia (CAP)in our hospital from October 2017 to October 2018 were selected and divided into two groups, namely MPP group (n=80)and non-MPP group (n=98). Serum MP antibody (MP-Ab)and throat swab MP-RNA were detected separately. The MP-Ab test was used as a reference for the analysis of accuracy of MP-SAT for MPP diagnosis. The MPP patients with positive MP-SAT and positive MP-Ab were observed dynamically. The detection rates of MP-SAT and MP-Ab in different treatment time points were compared. The correlation of MP-SAT negative time with clinical recovery time, clinical symptoms, laboratory parameters and chest X-ray was analyzed. Results The ratio of inconsistent MP-SAT and MP-Ab results was 60.00% (48/80)and 19.39% (19/98)in the MPP group and the non-MPP group, respectively. The MP-SAT and MP-Ab were statistically different in terms of specificity and positive predictive value (P<0.05), while no difference was found in the sensitivity and negative predictive value (P>0.05). Both MP-SAT and MP-Ab were positive in 28 cases (35.00%). The positive rate of MP-SAT was decreased with the prolongation of treatment time (P<0.05), meanwhile the positive rate of MP-Ab was increased with the treatment time (P<0.05); the clinical recovery time of 28 cases was (3.11±0.88)weeks, and the MP-SAT negative time was (3.25±0.74)weeks, with no statistical difference (P>0.05). The long-term duration of MP-SAT was characterized by long duration of fever, high consolidation rate of X-ray chest radiograph, high CRP level, high LDH level, high percentage of neutrophils, and low percentage of lymphocytes (P<0.05). Conclusion MP-SAT, as a new generation of RNA live bacteria detection technology, has high value in monitoring the efficacy of Mycoplasma pneumonia in children, and it is worth promoting.

1、 WEI H, XU X, LEI Y, et al. The role of the PM 2.5-associated metals in pathogenesis of child Mycoplasma Pneumoniae, infections: a systematic review[J]. Environ Sci Pollution Res, 2016, 23(11):10604-10614.

2、 DING Y, LEI X L, SUN D, et al. Expression and verification of miRNAs in peripheral blood of Mycoplasma pneumoniae pneumonia[J]. J Clin Pediatr, 2017,35(2):90-93.

3、 LI W, FANG Y H, SHEN H Q, et al. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of Mycoplasma pneumoniae infection in children with pneumonia[J]. Plos One, 2017, 12(5):e0177842.

4、林苗苗, 施李芬, 余坚,等. 肺炎支原体RNA和DNA检测技术对儿童肺炎支原体肺炎诊断的价值[J]. 中国妇幼保健, 2018,33(5):99-101.

5、冯雪莉,李勤静,徐保平,等. RNA恒温扩增检测技术在儿童肺炎支原体肺炎中的诊断价值评估[J]. 中华实用儿科临床杂志, 2016, 31(16):1222-1226.

6、王娟, 孙军, 高长龙, 等. 纤维支气管镜肺泡灌洗术治疗儿童难治性支原体肺炎疗效分析[J]. 临床儿科杂志, 2017, 35(1):16-18.

7、周成, 王书举, 翟玉峰, 等. 布地奈德雾化吸入对支原体肺炎患儿炎症因子与免疫功能的影响[J]. 中华医院感染学杂志, 2016, 26(9):2136-2138.

8、李晓品, 李艳红, 许凤勤, 等. 阿奇霉素对肺炎支原体肺炎感染患儿Th1/Th2指标的影响研究[J]. 中华医院感染学杂志, 2016, 26(16):3797-3799.

9、余丽丽, 赵德育. 肺炎支原体肺炎发病机制研究进展[J]. 中国实用儿科杂志, 2017, 32(3):234-238.

10、 WANG L, FENG Z, ZHAO M, et al. A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia[J]. BMC Infect Dis, 2017, 17(1):518.

11、 GUO L,SUN L,GUO Y, et al. Clinical value of Mycoplasma pneumoniae RNA detection in the monitoring of Mycoplasma pneumoniae pneumonia treatment in children[J]. Chin J Evid Based Pediatr, 2016,11(2):109-112.

12、郭丽,孙琳,郭琰,等. 肺炎支原体RNA检测在儿童肺炎支原体肺炎疗效监测中的应用价值[J]. 中国循证儿科杂志, 2016, 11(2):109-112.

13、薛峰, 李梅. 肺炎支原体感染应用孟鲁司特治疗的效果[J]. 新疆医学, 2016,46(1):87-88.

14、丁霞, 冉丹丹, 周闯. 血清降钙素原、白介素-6在肺炎支原体混合细菌感染早期诊断中的价值[J]. 新疆医学, 2018,48(11):88-90.

15、刘云琴, 张燕, 张智玲. 布地奈德混悬剂雾化吸入佐治小儿支原体肺炎临床观察[J]. 新疆医学, 2017,5(11):123-125.